Detalhe da pesquisa
1.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36692409
2.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36335916
3.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35854643
4.
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.
Haematologica
; 106(1): 39-45, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31879328
5.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
Am J Hematol
; 95(12): 1466-1472, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32777149
6.
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network.
Ann Hematol
; 97(11): 2107-2115, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30009341
7.
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Haematologica
; 107(4): 996-999, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35021604
8.
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome.
Am J Hematol
; 97(4): E135-E138, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35041232
9.
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda.
Cancers (Basel)
; 16(2)2024 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38254875
10.
Monoclonal gammopathy of undetermined significance: a new proposal of workup.
Eur J Haematol
; 91(4): 356-60, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23859528
11.
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).
Am J Hematol
; 93(2): E54-E57, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29164738
12.
Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia.
Pharmaceutics
; 15(6)2023 Jun 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37376128
13.
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
Cancers (Basel)
; 15(18)2023 Sep 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37760592
14.
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Blood Adv
; 7(16): 4448-4461, 2023 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37276451
15.
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.
Cancers (Basel)
; 15(13)2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37444567
16.
Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage.
Front Oncol
; 11: 726637, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34540694
17.
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL).
J Geriatr Oncol
; 12(4): 550-556, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33097455
18.
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper.
Crit Rev Oncol Hematol
; 158: 103203, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33388453
19.
Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: a retrospective analysis of the Rete Ematologica Lombarda.
Am J Hematol
; 90(6): E123-5, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25715978
20.
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program.
Blood Cancer J
; 10(10): 96, 2020 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33024084